Dr. Avdic is an Infectious Diseases Pharmacist and the Associate Director of the Antimicrobial Stewardship Program at The Johns Hopkins Hospital in Baltimore, Maryland. Dr. Avdic’s practice and research interests are in the area of antimicrobial stewardship and management of patients with multidrug-resistant organisms. Over the past 14 years, Dr. Avdic had worked to develop tools and methods that promote optimal antimicrobial use in hospital setting while minimize development of resistance. Dr. Avdic has presented at local and national meetings on a variety of infectious diseases pharmacotherapy topics and has authored numerous articles in peer-reviewed journals and textbook chapters. She serves as one of the pharmacology editors of The Johns Hopkins POC-IT ABX Guide and HIV Guide and had the authored over 80 drug modules. Dr. Avdic is actively involved in variety of professional pharmacy and infectious diseases organizations.
Cassiana E. Bittencourt received a doctor of medicine degree in Brazil (2003). She completed her clinical pathology residency in 2008 at the University of Sao Paulo. After receiving her education in Brazil, she moved to the United States, where she finished residency training in pathology at the University of South Florida (2015) and microbiology fellowship at UT Southwestern (2016). She is certified by the American Board of Pathology in Anatomic and Clinical Pathology as well as Medical Microbiology. In August 2016, she joined the Department of Pathology at UC Irvine as Medical Director of Microbiology and serves as an Assistant Professor of Clinical Pathology in the UC Irvine School of Medicine. Her interests include infectious disease histology, application of non-culture based diagnostic methods, and trainee education.
Dr. Butler-Wu is the Director of Clinical Microbiology at LAC+USC Medical Center and an Associate Professor of Clinical Pathology at the Keck School of Medicine of USC in Los Angeles, California, USA. Dr. Butler-Wu earned her PhD in Molecular Microbiology at Tufts University and completed her postdoctoral fellowship in Tuberculosis Pathogenesis at New York University (NYU). After completing a postdoctoral fellowship in Medical and Public Health Microbiology at the University of Washington in Seattle, she was the Associate Director of Clinical Microbiology at the University of Washington Medical Center until she moved to her current position. Dr. Butler-Wu’s research focuses on rapid diagnostics for infectious diseases. She is a member of the editorial board of the Journal of Clinical Microbiology, and serves on working groups of both the Clinical Laboratory Standards Institute and the American Society for Microbiology (ASM). She is a Diplomate of the American Board of Medical Microbiology.
Samuel Dominguez, MD, PhD is an Associate Professor of Pediatrics at the University of Colorado School of Medicine in the Division of Infectious Diseases. He is also an Associate Professor of Epidemiology in the School of Public Health. He serves as the Medical Director for the Clinical Microbiology Laboratory and the Associate Medical Director for Infection Control and Prevention at Children's Hospital Colorado. He obtained his undergraduate degree in chemistry and mathematics at Houghton college in 1992. He then completed the MD/PhD program at the University of Chicago. Dr. Dominguez completed his pediatric residency at the University of Chicago and his Pediatric Infectious Disease Fellowship at the University of Colorado, joining the faculty there in 2007. He has a research interest in clinical diagnostics and diagnostic stewardship, emerging infectious diseases, pediatric respiratory viral infections, enteroviruses, Acute Flaccid Myelitis, and Kawasaki disease. He is the author over 90 peer-reviewed publications.
Barbara A. Brown-Elliott, MS, MT(ASCP)SM, is an Associate Professor of Microbiology and Supervisor of the University of Texas Health Science Center at Tyler (UTHSCT) Mycobacteria/Nocardia Laboratory. She is a member of the American Society for Microbiology, and the Clinical and Laboratory Standards Institute Subcommittee on Antimycobacterial Susceptibility Testing. She is the author of more than 175 scientific articles and chapters and more than 100 abstracts. She is the 2009 recipient of the Becton Dickinson Gardner Middlebrook Award for significant contributions in mycobacteriology, the 2013 ASM Scherago-Rubin Award for excellence in clinical microbiology and was selected as an ASM distinguished speaker for 2019-2020.
Dr. Humphries is a clinical microbiologist and Chief Scientific Officer of Accelerate Diagnostics. She is the author of >100 peer-reviewed papers, and active in ASM, CLSI and CAP.
Dr. Peera Hemarajata is an Assistant Director at LA County Public Health Laboratories and a certified American Board of Medical Microbiology (ABMM) Diplomate. Prior to joining the County, he completed a Postdoctoral Fellowship in Medical and Public Health Microbiology at David Geffen School of Medicine at UCLA, and was later appointed as a Clinical Instructor in Pathology and Laboratory Medicine. Dr. Hemarajata received his M.D. from Chulalongkorn University in Bangkok, Thailand and Ph.D. in Molecular Virology and Microbiology from Baylor College of Medicine in Houston, TX.
Dr. Pergam is an Associate Member at the Fred Hutchinson Cancer Research Center in the Divisions of Clinical Research and Vaccine and Infectious Disease, and an Associate Professor in the Division of Allergy & Infectious Diseases at the University of Washington Medical Center in Seattle, WA. He serves as the Director of Infection Prevention at the Seattle Cancer Care Alliance, and his research interests involve hospital epidemiology, antimicrobial resistance, and infection prevention in immunosuppressed hosts. His group focuses on infection prevention, resistant pathogens, antimicrobial stewardship, and on the development of novel prevention strategies for community and healthcare-associated infections in cancer and hematopoietic cell transplant patients. He has active research projects that evaluate vaccinations, water-borne pathogens, resistant bacteria, respiratory virus transmission, and fungal infections among immunocompromised hosts. Dr Pergam is also a cancer survivor with a strong interest in community engagement and education regarding medical research and science.
Dr. Trish Simner, PhD, D(ABMM), is an Associate Professor of Pathology at the Johns Hopkins University School of Medicine and the Director of the Medical Bacteriology and Parasitology Laboratories at the Johns Hopkins Medical Institutions. Her research has focused on understanding the epidemiology and molecular mechanisms of resistance of Gram-negative bacteria, in particular those harboring β-lactamase enzymes. She is also interested in novel diagnostic tools for infectious diseases and is actively involved in developing metagenomic next-generation sequencing as a diagnostic tool.
Dr. Simner is a voting member on the Subcommittee on Antimicrobial Susceptibility Testing for the Clinical and Laboratory Standards Institute, she is the Early Career At-Large representative for the American Society for Microbiology (ASM) Council on Microbial Sciences and an Editorial Board Member for the Journal of Clinical Microbiology.
Dr. Van is Director of the Clinical Microbiology Laboratory at Harbor-UCLA Medical Center and an Assistant Clinical Professor at David Geffen School of Medicine at UCLA.
Dr. Van received her PhD at the University of Wisconsin-Madison and obtained an Emerging Infectious Disease Research Fellowship at the Wisconsin State Laboratory of Hygiene. After several years working in public health, she completed a Clinical Microbiology Fellowship at Children’s Hospital Los Angeles and is currently a diplomate of the American Board of Medical Microbiology.
Dr. Van Horn received his PhD in Anaerobic Microbiology from Virginia Tech followed by a Post-doctoral Fellowship at Montefiore medical Center in the Bronx, NY. He served as Chief of Microbiology at Westchester Medical Center for 18 years then 1 ½ years as Microbiology Director at Mt. Sinai in New Your City. In 2005, he moved to California and became Scientific dDrector at Focus Diagnostics before eventually becoming Technical Director of Microbiology Services at Kaiser Permanente in 2016. He has over 30 peer reviewed manuscripts and multiple abstract and poster presentations at ASM meetings.
Dr. Westblade, Ph.D, D(ABMM) is an Associate Professor in Pathology and Laboratory Medicine at Weill Cornell Medicine and the Director of Clinical Microbiology at New York Presbyterian-Weill Cornell Medical Center. He did his undergraduate and postgraduate training in biochemistry at the University of Birmingham, UK; followed by postgraduate studies at The Rockefeller University, US. Subsequently, he completed a CPEP-approved fellowship in Medical and Public Health Laboratory Microbiology at Washington University School of Medicine in St. Louis, US. He has a special interest in antimicrobial resistance mechanisms and Weirdobacter weirdii microorganisms that keep clinical microbiologists excited!
Dr. Yang earned his PhD in Molecular Biology and Biochemistry from the University of Southern California. After that he worked as a CLS for 7 years before going through the Clinical Microbiology Fellowship training at UCLA and became board certified by the American Board of Medical Microbiology. Dr. Yang is currently an Assistant Professor in the Department of Pathology and Laboratory Medicine at UCLA, and serves as the Assistant Medical Director of Clinical Microbiology Laboratory. Dr. Yang’s main expertise includes molecular diagnostics and innovation, microbial genomics, antimicrobial resistance mechanisms and prediction, molecular epidemiology and applications of NGS in infectious diseases.